Market Research Logo

Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial) & Application Category - Forecasts to 2021

Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial) & Application Category - Forecasts to 2021

The vaccine adjuvants market is expected to reach USD 769.4 million by 2021 from USD 467.0 million in 2016, at a CAGR of 10.5%. The global vaccine adjuvants market is segmented based on product type, route of administration, disease type, applications, and application categories.

On the basis of type, the vaccine adjuvants market is segmented into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and others. The particulate adjuvants segment is expected to account for the largest share of the global vaccine adjuvants market in 2016. Growth in this segment can primarily be attributed to increasing investments in research.

On the basis of route of administration, the market is segmented into subcutaneous, intranasal, intramuscular, intradermal, and others. The intramuscular segment is expected to account for the largest share of the global vaccine adjuvants market in 2016. Increasing prevalence of diseases and the need for new vaccine adjuvants with better efficacy will drive the growth of this market.

Geographically, the vaccine adjuvants market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by the rapidly increasing aging population and rising government funding in the North American countries.

The major factors contributing to the growth of the vaccine adjuvants market include increasing government funding for research, high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and growing focus on improved vaccination. Furthermore, increasing R&D spending as well as acquisitions, collaborations, and agreements by companies is another major factor driving the growth of this market.

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the market.

The major players in the vaccine adjuvants market are Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (France), Agenus, Inc. (U.S.), Novavax, Inc. (U.S.), SPI Pharma, Inc. (U.S.), Invivogen (U.S.), Avanti Polar Lipids, Inc. (U.S.), MPV Technologies (U.S.), and OZ Biosciences (France).

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product portfolios of the top players in the vaccine adjuvants market. The report analyzes the vaccine adjuvants market by type, route of administration, disease type, applications, and target group
• Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the vaccine adjuvants market
• Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the vaccine adjuvants market
• Market Development: Comprehensive information about emerging markets. This report analyzes the market for various vaccine adjuvants across geographies
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the vaccine adjuvants market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKET SEGMENTATION
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • MARKET STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • KEY INDICATORS
      • INTRODUCTION
      • MACROINDICATORS
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • KEY DATA FROM SECONDARY SOURCES
    • KEY DATA FROM PRIMARY SOURCES
    • KEY INDUSTRY INSIGHTS
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
    • INTRODUCTION
    • CURRENT SCENARIO
    • FUTURE OUTLOOK
    • CONCLUSION
  • PREMIUM INSIGHTS
    • VACCINE ADJUVANTS MARKET OVERVIEW
    • VACCINE ADJUVANTS MARKET, BY APPLICATION
    • GEOGRAPHICAL SNAPSHOT OF THE VACCINE ADJUVANTS MARKET
    • GEOGRAPHIC ANALYSIS: VACCINE ADJUVANTS MARKET, BY APPLICATION CATEGORY
    • GEOGRAPHIC ANALYSIS: VACCINE ADJUVANTS MARKET, BY DISEASE TYPE
    • LIFECYCLE ANALYSIS, BY REGION, 2015
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
        • Table INCREASING USE OF ADJUVANTS IN VACCINE-PREVENTABLE DISEASES DRIVES THE MARKET GROWTH
      • RESTRAINTS
        • Table HIGH COST OF ADJUVANT RESEARCH RESTRAINTS THE MARKET GROWTH
      • OPPORTUNITIES
        • Table COMBINED ADJUVANTS AND PANDEMIC DISEASES OFFER GROWTH OPPORTUNITIES FOR MARKET PLAYERS
      • CHALLENGES
        • Table IDENTIFICATION OF ADJUVANTS CHALLENGES THE GROWTH OF THIS MARKET
      • Trends
        • Table COLLABORATIONS OFFER GROWTH TRENDS FOR MARKET PLAYERS
    • KEY PIPELINE PRODUCTS
      • Table FDA APPROVED VACCINE ADJUVANTS
      • Table LICENSED VACCINES CONTAINING ADJUVANTS
      • Table EXAMPLES OF VACCINE ADJUVANTS IN CLINICAL TRIALS
    • REGULATORY LANDSCAPE
      • NORTH AMERICA
      • EUROPE
      • ASIA
      • ROW
  • GLOBAL VACCINE ADJUVANTS MARKET, BY PRODUCT TYPE
    • INTRODUCTION
      • Table VACCINE ADJUVANTS MARKET SIZE, BY PRODUCT TYPE, 2014-2021
    • PARTICULATE ADJUVANTS
      • Table LIST OF PARTICULATE ADJUVANTS APPROVED FOR HUMAN USE (2015)
      • Table PARTICULATE ADJUVANTS MARKET SIZE, BY REGION, 2014-2021(USD MILLION)
      • Table NORTH AMERICA PARTICULATE ADJUVANTS MARKET SIZE, BY COUNTRY, 2014-2021(USD MILLION)
      • Table EUROPE PARTICULATE ADJUVANTS MARKET SIZE, BY COUNTRY, 2014-2021(USD MILLION)
      • Table ASIA PARTICULATE ADJUVANTS MARKET SIZE, BY COUNTRY, 2014-2021(USD MILLION)
    • ADJUVANT EMULSIONS
      • Table LIST OF ADJUVANT EMULSIONS APPROVED FOR HUMAN USE (2015)
      • Table ADJUVANTS EMULSION MARKET SIZE, BY REGION, 2014-2021(USD MILLION)
      • Table NORTH AMERICA ADJUVANT EMULSIONS MARKET SIZE, BY COUNTRY, 2014-2021(USD MILLION)
      • Table EUROPE ADJUVANT EMULSIONS MARKET SIZE, BY COUNTRY, 2014-2021(USD MILLION)
      • Table ASIA ADJUVANT EMULSIONS MARKET SIZE, BY COUNTRY, 2014-2021(USD MILLION)
    • PATHOGEN COMPONENTS
      • Table PATHOGEN COMPONENTS AND ITS DESCRIPTION
      • Table PATHOGEN COMPONENTS MARKET SIZE, BY REGION, 2014-2021(USD MILLION)
      • Table NORTH AMERICA PATHOGEN COMPONENTS MARKET SIZE, BY COUNTRY, 2014-2021(USD MILLION)
      • Table EUROPE PATHOGEN COMPONENTS MARKET SIZE, BY COUNTRY, 2014-2021(USD MILLION)
      • Table ASIA PATHOGEN COMPONENTS MARKET SIZE, BY COUNTRY, 2014-2021(USD MILLION)
    • COMBINATION ADJUVANTS
      • Table LIST OF COMBINATION ADJUVANT APPROVED FOR HUMAN USE (2015)
      • Table COMBINATION ADJUVANTS MARKET SIZE, BY REGION, 2014-2021(USD MILLION)
      • Table NORTH AMERICA COMBINATION ADJUVANTS MARKET SIZE, BY COUNTRY, 2014-2021(USD MILLION)
      • Table EUROPE COMBINATION ADJUVANTS MARKET SIZE, BY COUNTRY, 2014-2021(USD MILLION)
      • Table ASIA COMBINATION ADJUVANTS MARKET SIZE, BY COUNTRY, 2014-2021(USD MILLION)
    • OTHERS
      • Table OTHER ADJUVANTS AND ITS DESCRIPTION
      • Table OTHERS ADJUVANTS MARKET SIZE, BY REGION, 2014-2021(USD MILLION)
      • Table NORTH AMERICA OTHERS VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2014-2021(USD MILLION)
      • Table EUROPE OTHERS VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2014-2021(USD MILLION)
      • Table ASIA OTHERS VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2014-2021(USD MILLION)
  • GLOBAL VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION
    • INTRODUCTION
      • Table VACCINE ADJUVANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021(USD MILLION)
    • INTRAMUSCULAR ROUTE
      • Table INTRAMUSCULAR ROUTE OF ADMINISTRATION MARKET SIZE, BY REGION, 2014-2021(USD MILLION)
    • SUBCUTANEOUS ROUTE
      • Table SUBCUTANEOUS ROUTE OF ADMINISTRATION MARKET SIZE, BY REGION, 2014-2021(USD MILLION)
    • INTRANASAL ROUTE
      • Table INTRANASAL ROUTE OF ADMINISTRATION MARKET SIZE, BY REGION, 2014-2021(USD MILLION)
    • ORAL ROUTE
      • Table ORAL ROUTE OF ADMINISTRATION MARKET SIZE, BY REGION, 2014-2021(USD MILLION)
    • INTRADERMAL ROUTE
      • Table INTRADERMAL ROUTE OF ADMINISTRATION MARKET SIZE, BY REGION, 2014-2021(USD MILLION)
    • OTHERS
      • Table OTHERS ROUTE OF ADMINISTRATION MARKET SIZE, BY REGION, 2014-2021(USD MILLION)
  • GLOBAL VACCINE ADJUVANT MARKET, BY DISEASE TYPE
    • INTRODUCTION
      • Table VACCINE ADJUVANTS MARKET SIZE, BY DISEASE TYPE, 2014-2021(USD MILLION)
    • INFECTIOUS DISEASES
      • Table NEW CASES OF DISEASES (2014)
      • Table INFECTIOUS DISEASES VACCINE ADJUVANTS MARKET SIZE, BY REGION, 2014-2021(USD MILLION)
    • CANCER
      • Table CANCER DISEASE VACCINE ADJUVANTS MARKET SIZE, BY REGION, 2014-2021(USD MILLION)
    • OTHERS
      • Table OTHERS VACCINE ADJUVANTS MARKET SIZE, BY REGION, 2014-2021(USD MILLION)
  • GLOBAL VACCINE ADJUVANTS MARKET, BY APPLICATION
    • INTRODUCTION
      • Table VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2014-2021(USD MILLION)
    • RESEARCH APPLICATION
      • Table VACCINE ADJUVANTS MARKET, BY RESEARCH APPLICATION, BY REGION, 2014-2021(USD MILLION)
    • COMMERCIAL APPLICATION
      • Table VACCINE ADJUVANTS MARKET, BY COMMERCIAL APPLICATION, BY REGION, 2014-2021(USD MILLION)
  • GLOBAL VACCINE ADJUVANTS MARKET, BY APPLICATION CATEGORY
    • INTRODUCTION
      • Table VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION CATEGORY, 2014-2021 (USD MILLION)
    • HUMAN VACCINE ADJUVANTS
      • Table LIST OF ADJUVANTS APPROVED FOR HUMAN USE BY FDA
      • Table HUMAN VACCINE ADJUVANTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
    • VETERINARY VACCINE ADJUVANTS
      • Table VETERINARY VACCINE ADJUVANTS MARKET SIZE, BY REGION, 2014-2021(USD MILLION)
  • GLOBAL VACCINE ADJUVANTS MARKET, BY REGION
    • INTRODUCTION
      • Table VACCINE ADJUVANTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table EUROPE: VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table ASIA: VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: VACCINE ADJUVANTS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: VACCINE ADJUVANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: VACCINE ADJUVANTS MARKET SIZE, BY DISEASE TYPE, 2014-2021(USD MILLION)
      • Table NORTH AMERICA: VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2014-2021(USD MILLION)
      • Table NORTH AMERICA: VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION CATEGORY, 2014-2021(USD MILLION)
      • U.S.
        • Table U.S.: VACCINE ADJUVANTS MARKET SIZE, BY PRODUCT TYPE, 2014-2021, (USD MILLION)
      • CANADA
        • Table CANADA: VACCINE ADJUVANTS MARKET SIZE, BY PRODUCT TYPE, 2014-2021(USD MILLION)
    • EUROPE
      • Table EUROPE: VACCINE ADJUVANTS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
      • Table EUROPE: VACCINE ADJUVANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD MILLION)
      • Table EUROPE: VACCINE ADJUVANTS MARKET SIZE, BY DISEASE TYPE, 2014-2021(USD MILLION)
      • Table EUROPE: VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2014-2021(USD MILLION)
      • Table EUROPE: VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION CATEGORY, 2014-2021 (USD MILLION)
      • GERMANY
        • Table GERMANY: VACCINE ADJUVANTS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
      • U.K.
        • Table U.K.: VACCINE ADJUVANTS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
      • FRANCE
        • Table FRANCE: VACCINE ADJUVANTS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
      • REST OF EUROPE
        • Table REST OF EUROPE: VACCINE ADJUVANTS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
    • ASIA
      • Table ASIA: VACCINE ADJUVANTS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
      • Table ASIA: VACCINE ADJUVANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD MILLION)
      • Table ASIA: VACCINE ADJUVANTS MARKET SIZE, BY DISEASE TYPE, 2014-2021(USD MILLION)
      • Table ASIA: VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2014-2021(USD MILLION)
      • Table ASIA: VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION CATEGORY, 2014-2021(USD MILLION)
      • CHINA
        • Table CHINA: VACCINE ADJUVANTS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
      • INDIA
        • Table INDIA: VACCINE ADJUVANTS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
      • REST OF ASIA
        • Table REST OF ASIA: VACCINE ADJUVANTS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
    • REST OF THE WORLD
      • Table REST OF THE WORLD: VACCINE ADJUVANTS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
      • Table REST OF THE WORLD: VACCINE ADJUVANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD MILLION)
      • Table REST OF THE WORLD: VACCINE ADJUVANTS MARKET SIZE, BY DISEASE TYPE, 2014-2021(USD MILLION)
      • Table REST OF THE WORLD: VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION, 2014-2021(USD MILLION)
      • Table REST OF THE WORLD: VACCINE ADJUVANTS MARKET SIZE, BY APPLICATION CATEGORY, 2014-2021(USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET SHARE ANALYSIS
    • COMPETITIVE SITUATION AND TRENDS
      • AGREEMENTS & COLLABORATIONS
        • Table AGREEMENTS & COLLABORATIONS, 2015
      • ACQUISITIONS
        • Table ACQUISITIONS, 2015-2016
      • EXPANSIONS
        • Table EXPANSIONS, 2014
      • OTHERS
        • Table OTHERS, 2014-2015
  • COMPANY PROFILE
    • INTRODUCTION
    • BRENNTAG BIOSECTOR A/S (A SUBSIDIARY OF BRENNTAG AG)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2013-2016)
      • MNM VIEW
    • SEPPIC (A SUBSIDIARY OF AIR LIQUIDE GROUP)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2013-2016)
      • MNM VIEW
    • CSL LIMITED
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2013-2016)
      • MNM VIEW
    • AGENUS, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2013-2016)
    • NOVAVAX, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS(2013-2016)
    • INVIVOGEN
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • SPI PHARMA, INC. (A SUBSIDIARY OF ASSOCIATED BRITISH FOODS PLC.)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS(2013-2016)
    • AVANTI POLAR LIPIDS, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • MVP LABORATORIES INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS(2013-2016)
    • OZ BIOSCIENCES
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • RELATED REPORTS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report